Advertisement

Experientia

, Volume 8, Issue 5, pp 184–185 | Cite as

Über einige heterozyklische Thiosemicarbazone

  • R. E. Hagenbach
  • H. Gysin
Kurze Mitteilungen

Summary

Description of 30 thiosemicarbazones of heterocyclic Aldehydes. Some of these compounds show tuberculostatic activityin vivo superior to p-Acetylaminobenzal-dehyde-thiosemicarbazone which statement was already made independently by French and American research groups. In the series of heterocyclic thiosemicarbazones very small changes in the molecular structure may cause a total loss of the tuberculostatic properties.

References

  1. 1.
    G. Domagk, R. Behnisch, F. Mietzsch undH. Schmidt, Naturwissenschaften33, 315 (1946).Google Scholar
  2. 2.
    G. Domagk, R. Behnisch, F. Mietzsch undH. Schmidt, Angew. Chemie60, 113 (1948).Google Scholar
  3. 3.
    Geschützter Handelsname.Google Scholar
  4. 4.
    Die Ergebnisse sind in Patentanmeldungen niedergelegt.Google Scholar
  5. 5.
    C. Levaditi, A. Girard, A. Vaisman undA. Ray, Presse méd.58, 1326 (1950); C. r. Acad. Sci.231, 1174 (1950); Presse méd.59, 213 (1951); C. r. Acad. Sci. Soc. biol.145, 60, 861, 864 (1951); C. r. Acad. Sci.232, 770 (1951); Presse méd.59, 1606 (1951).Google Scholar
  6. 5a.
    E. Grunberg undB. Leiwant, Proc. Soc. Exp. Biol. Med.77, 47 (1951).PubMedGoogle Scholar
  7. 5b.
    Th. S. Gardner, F. A. Smith, E. Wenis undJ. Lee, J. org. Chem.16, 1121 (1951).Google Scholar
  8. 1.
    C. Levaditi, A. Girard, A. Vaisman undA. Ray, Presse méd.58, 1326 (1950); C. r. Acad. Sci.231, 1174 (1950); Presse méd.59, 213 (1951); C. r. Acad. Sci. Soc. biol.145, 60, 861, 864 (1951); C. r. Acad. Sci.232, 770 (1951); Presse méd.59, 1606 (1951).Google Scholar
  9. 1a.
    E. Grunberg undB. Leiwant, Proc. Soc. exp. Biol. Med.77, 47 (1951).PubMedGoogle Scholar
  10. 1b.
    Th. S. Gardener, F. A. Smith, E. Wenis undJ. Lee, J. org. Chem.16, 1121 (1951).Google Scholar
  11. 2a.
    G. Domagk, R. Behnisch, F. Mietzsch undH. Schmidt, Angew. Chemie60, 113 (1948).Google Scholar
  12. 2a.
    Zum BeispielE. Hoggarth, A. R. Martin, N. E. Storey undE. H. P. Young, Brit. J. Pharmacol.4, 248 (1949).Google Scholar
  13. 2b.
    R. Hirt undH. Hurni, Schweiz. Z. Path. Bakt.13, 469 (1950).Google Scholar
  14. 2c.
    R. Donovick undJ. Bernstein et al., J. Bact.59, 667 und 675 (1950).PubMedGoogle Scholar
  15. 3.
    Zum BeispielE. Hoggarth, A. R. Martin, N. E. Storey undE. H. P. Young, Brit. J. Pharmacol.4, 248 (1949).Google Scholar
  16. 3a.
    R. Hirt undH. Hurni, Schweiz. Z. Path. Bakt.13, 469 (1950).Google Scholar
  17. 3b.
    R. Donovick undJ. Bernstein et al., J. Bact.59, 667, 675 (1950).PubMedGoogle Scholar
  18. 1.
    C. Levaditi et al., C. r. Acad. Sci.231, 1174 (1950); Smp. 227–230°.Google Scholar
  19. 1a.
    Th. S. Gardner et al., J. org. Chem.16, 1121 (1951); Smp. 222–223°.Google Scholar
  20. 2.
    E. Grunberg undB. Leiwant, Proc. Soc. exp. Med.77, 47 (1951), keine Smp.-Angabe.Google Scholar
  21. 3.
    E. Grunberg et al., l. c.: keine Smp.-Angabe.Google Scholar
  22. 4.
    J. Bernstein et al., Amer. Soc.73, 906 (1951); Smp. 149–150°.Google Scholar
  23. 4a.
    Fl. E. Anderson et al., Amer. Soc.73, 4967 (1951); Smp. 152–154°.Google Scholar
  24. 5.
    O. Dann et al., Ber. dtsch. Chem. Ges.82, 76 (1949); Smp. 229°.Google Scholar
  25. 5a.
    P. P. T. Sah et al., Rec. trav. chim. Pays-Bas69, 1545 (1950); Smp. 236–237°.Google Scholar
  26. 5b.
    US. 2416239; allmähliche Zersetzung.Google Scholar
  27. 5c.
    EP. 620888; keine Smp.-Angabe.Google Scholar
  28. 6.
    J. Bernstein et al., l. c.; Smp. 186–187°.Google Scholar
  29. 6a.
    Fl. E. Anderson et al., l. c.; Smp. 185–186°.Google Scholar
  30. 7.
    Th. S. Gardner et al., l. c.; Smp. 226–227°.Google Scholar
  31. 8.
    Fl. E. Anderson et al., l. c.; Smp. 195–197°.Google Scholar

Copyright information

© Birkhäuser Verlag 1952

Authors and Affiliations

  • R. E. Hagenbach
    • 1
  • H. Gysin
    • 1
  1. 1.Wissenschaftliche Laboratorien der J. R. Geigy AG.Basel

Personalised recommendations